Pre-operative computed tomography coronary angiography to detect significant coronary artery disease in patients referred for cardiac valve surgery

J Am Coll Cardiol. 2006 Oct 17;48(8):1658-65. doi: 10.1016/j.jacc.2006.06.054. Epub 2006 Sep 26.

Abstract

Objectives: We studied the diagnostic performance of 64-slice computed tomography coronary angiography (CTCA) to rule out or detect significant coronary stenosis in patients referred for valve surgery.

Background: Invasive conventional coronary angiography (CCA) is recommended in most patients scheduled for valve surgery.

Methods: During a 6-month period, 145 patients were prospectively identified from a consecutive patient population scheduled for valve surgery. Thirty-five patients were excluded because of CTCA criteria: irregular heart rhythm (n = 26), impaired renal function (n = 5), and known contrast allergy (n = 4). General exclusion criteria were: hospitalization in community hospital (n = 4), no need for CCA (n = 4), previous coronary artery bypass surgery (n = 1), or percutaneous coronary intervention (n = 4). Of the remaining 97 patients, 27 denied written informed consent. Thus, the study population comprised 70 patients (49 male, 21 female; mean age 63 +/- 11 years).

Results: Prevalence of significant coronary artery disease, defined as having at least 1 > or =50% stenosis per patient, was 25.7%. Beta-blockers were administered in 71%, and 64% received lorazepam. The mean heart rate dropped from 72.5 +/- 12.4 to 59.5 +/- 7.5 beats/min. The mean scan time was 12.8 +/- 1.3 s. On a per-patient analysis, the sensitivity, specificity, and positive and negative predictive values were: 100% (18 of 18; 95% confidence interval [CI] 78 to 100), 92% (48 of 52; 95% CI 81 to 98), 82% (18 of 22; 95% CI 59 to 94), and 100% (48 of 48; 95% CI 91 to 100), respectively.

Conclusions: The diagnostic accuracy of 64-slice CTCA for ruling out the presence of significant coronary stenoses in patients undergoing valve surgery is excellent and allows CTCA implementation as a gatekeeper for invasive CCA in these patients.

Publication types

  • Evaluation Study

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Aged
  • Coronary Angiography* / standards
  • Coronary Stenosis / diagnostic imaging*
  • Coronary Stenosis / drug therapy
  • Coronary Stenosis / epidemiology
  • Coronary Stenosis / physiopathology
  • Female
  • Heart Rate / drug effects
  • Heart Valve Diseases / surgery*
  • Humans
  • Lorazepam / therapeutic use
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Preoperative Care*
  • Prevalence
  • Prospective Studies
  • Referral and Consultation
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed* / standards

Substances

  • Adrenergic beta-Antagonists
  • Lorazepam